About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 497242, 8 pages
http://dx.doi.org/10.1155/2012/497242
Research Article

Assessment of Anticholinesterase Activity of Gelidiella acerosa: Implications for Its Therapeutic Potential against Alzheimer’s Disease

Department of Biotechnology, Alagappa University, Tamil Nadu, Karaikudi 630 003, India

Received 19 August 2012; Revised 8 October 2012; Accepted 25 October 2012

Academic Editor: Andrew Scholey

Copyright © 2012 Arif Nisha Syad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Cummings, H. V. Vinters, G. M. Cole, and Z. S. Khachaturian, “Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities,” Neurology, vol. 51, no. 1, pp. S2–S17, 1998. View at Scopus
  2. R. D. Terry and R. Katzman, “Senile dementia of the Alzheimer type,” Annals of Neurology, vol. 14, no. 5, pp. 497–506, 1983. View at Scopus
  3. M. Irizarry and B. Hyman, “Alzheimer’s disease,” in Principles of Neuroepidemiology, T. Batchlor and M. Cudkowicz, Eds., pp. 69–98, Butterworth-Heinemann, Boston, Mass, USA, 2001.
  4. J. C. Jaén, V. E. Gregor, C. Lee, R. Davis, and M. Emmerling, “Acetylcholinesterase inhibition by fused dihydroquinazoline compounds,” Bioorganic and Medicinal Chemistry Letters, vol. 6, no. 6, pp. 737–742, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. L. S. Schneider, “New therapeutic approaches to Alzheimer's disease,” Journal of Clinical Psychiatry, vol. 57, supplement 14, pp. 30–36, 1996. View at Scopus
  6. S. Darvesh, R. Walsh, R. Kumar et al., “Inhibition of human cholinesterases by drugs used to treat Alzheimer disease,” Alzheimer Disease and Associated Disorders, vol. 17, no. 2, pp. 117–126, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Zarotsky, J. J. Sramek, and N. R. Cutler, “Galantamine hydrobromide: an agent for Alzheimer's disease,” American Journal of Health-System Pharmacy, vol. 60, no. 5, pp. 446–452, 2003. View at Scopus
  8. D. J. McHugh, “A guide to seaweed industry,” FAO Fisheries Technical Paper no. 441, FAO, Rome, Italy, 2003.
  9. K. Hayashi, J. Mori, H. Saito, and T. Hayashi, “Antiviral targets of a chromene derivative from Sargassum micracanthum in the replication of human cytomegalovirus,” Biological and Pharmaceutical Bulletin, vol. 29, no. 9, pp. 1843–1847, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. P. F. Dias, J. M. Siqueira, L. F. Vendruscolo et al., “Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum,” Cancer Chemotherapy and Pharmacology, vol. 56, no. 4, pp. 436–446, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Prasad, A. K. Siddhanta, M. Ganesan, B. K. Ramavat, B. Jha, and P. K. Ghosh, “Agars of Gelidiella acerosa of west and southeast coasts of India,” Bioresource Technology, vol. 98, no. 10, pp. 1907–1915, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. S. Premakumara, W. D. Ratnasooriya, L. M. V. Tillekeratne, A. S. Amarasekare, and A. U. Rahman, “Human sperm motility stimulating activity of a sulfono glycolipid isolated from Sri Lankan marine red alga Gelidiella acerosa,” Asian Journal of Andrology, vol. 3, no. 1, pp. 27–31, 2001. View at Scopus
  13. G. A. S. Premakumara, W. D. Ratnasooriya, and L. M. V. Tillekeratne, “Isolation of a non-steroidal contragestative agent from Sri Lankan marine red alga, Gelidiella acerosa,” Contraception, vol. 54, no. 6, pp. 379–383, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. K. P. Devi, N. Suganthy, P. Kesika, and S. K. Pandian, “Bioprotective properties of seaweeds: in vitro evaluation of antioxidant activity and antimicrobial activity against food borne bacteria in relation to polyphenolic content,” BMC Complementary and Alternative Medicine, vol. 8, article 38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. M. Oza and A. Zaidu, Revised Checklist of Indian Marine Alage, Central Salt and Marine Chemicals Research Institute, Bhavnagar, India, 2003.
  16. V. Krishnamurthy and H. Y. Joshi, A Check List of Indian Marine Algae, Central Salt and Marine Chemicals Research Institute, Bhavnagar, India, 1970.
  17. G. L. Ellman, K. D. Courtney, V. Andres, and R. M. Featherstone, “A new and rapid colorimetric determination of acetylcholinesterase activity,” Biochemical Pharmacology, vol. 7, no. 2, pp. 88–95, 1961. View at Scopus
  18. K. Ingkaninan, C. M. De Best, R. Van Der Heijden et al., “High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products,” Journal of Chromatography A, vol. 872, no. 1-2, pp. 61–73, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. G. E. Trease and W. C. Evans, Pharmacognosy, Bailliere Tindall, London, UK, 13th edition, 1989.
  20. A. Sofowora, Medicinal Plants and Traditional Medicine in Africa, Spectrum Books, Ibadan, Nigeria, 1993.
  21. J. B. Harborne, Phytochemical Methods, Chapman and Hall, London, UK, 1973.
  22. J. B. Harborne, Phytochemical Methods- A Guide to Modern Techniques of Plant Analysis, Chapman and Hall, London, UK, 1980.
  23. H. Wagner, S. Bladt, and E. M. Zygainski, Plant Drug Analysis- A Thin Layer Chromatography Atlas, Springer, Berlin, Germany, 1984.
  24. S. H. Karmarkar, R. Keshavachandran, and A. Augustin, “Biochemical evaluation of root tubers and in vitro induced callus of adapathiyan (HOLOSTEMMA ADA-KODIEN K. SCHUM.),” Journal of Tropical Agriculture, vol. 39, pp. 108–110, 2001.
  25. T. Benie and M. L. Thieulant, “Interaction of some traditional plant extracts with uterine oestrogen or progestin receptors,” Phytotherapy Research, vol. 17, no. 7, pp. 756–760, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Balzarini, A. I. Hernández, P. Roche et al., “Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifunctional deoxynucleoside kinase,” Molecular Pharmacology, vol. 63, no. 2, pp. 263–270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Giacobini, “Drugs that target cholinesterase,” in Cognitive Enhancing Drugs, J. J. Buccafusco, Ed., pp. 11–36, Birkhäuser, Basel, Switzerland, 2004.
  28. J. R. Hodges, “Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects,” Brain, vol. 129, no. 11, pp. 2811–2822, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Zimmermann, F. Gardoni, E. Marcello et al., “Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines,” Journal of Neurochemistry, vol. 90, no. 6, pp. 1489–1499, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. N. H. Greig, T. Utsuki, Q. S. Yu et al., “A new therapeutic target in Alzheimer's disease treatment: attention to butyryloholinesterase,” Current Medical Research and Opinion, vol. 17, no. 3, pp. 159–165, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. P. K. Mukherjee, V. Kumar, M. Mal, and P. J. Houghton, “Acetylcholinesterase inhibitors from plants,” Phytomedicine, vol. 14, no. 4, pp. 289–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Menichini, R. Tundis, M. R. Loizzo et al., “Acetylcholinesterase and butyrylcholinesterase inhibition of ethanolic extract and monoterpenes from Pimpinella anisoides V Brig. (Apiaceae),” Fitoterapia, vol. 80, no. 5, pp. 297–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. J. Chang, H. J. Kim, and H. S. Chun, “Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids,” Life Sciences, vol. 80, no. 9, pp. 835–841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Mu, J. Kou, D. Zhu, and B. Yu, “Comparison of neuroprotective effects of flavonoids, terpenoids, and their combinations from Ginkgo biloba on ischemia-reperfusion—injured mice,” Pharmaceutical Biology, vol. 45, no. 9, pp. 728–733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Kivrak, M. E. Duru, M. Öztürk, N. Mercan, M. Harmandar, and G. Topçu, “Antioxidant, anticholinesterase and antimicrobial constituents from the essential oil and ethanol extract of Salvia potentillifolia,” Food Chemistry, vol. 116, no. 2, pp. 470–479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Shiomi, “Meroterpenoids with various biological activities produced by fungi,” Pure and Applied Chemistry, vol. 71, no. 6, pp. 1059–1064, 1999. View at Scopus
  37. S. U. Savelev, E. J. Okello, and E. K. Perry, “Butyryl- and acetylcholinesterase inhibitory activities in essential oils of Salvia species and their constituents,” Phytotherapy Research, vol. 18, no. 4, pp. 315–324, 2004. View at Publisher · View at Google Scholar · View at Scopus